Anzeige
Mehr »
Donnerstag, 27.11.2025 - Börsentäglich über 12.000 News
Dieser Deal könnte bedeutend sein - SMR könnte einen neuen Hype auslösen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D1VX | ISIN: CA25245D1033 | Ticker-Symbol: D75
Frankfurt
27.11.25 | 08:07
0,039 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
DIAGNAMED HOLDINGS CORP Chart 1 Jahr
5-Tage-Chart
DIAGNAMED HOLDINGS CORP 5-Tage-Chart

Aktueller Chart DIAGNAMED Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
DIAGNAMED HOLDINGS CORP-Investoren interessieren sich auch für diese Wertpapiere
PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue GuidanceSAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative...
► Artikel lesen
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue GuidanceSAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative...
► Artikel lesen
PROCEPT BioRobotics President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEOLarry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing...
► Artikel lesen
Zynex, Inc.: Zynex Reports Third Quarter 2025 Financial ResultsENGLEWOOD, Colo., Nov. 17, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of...
► Artikel lesen
Zynex, Inc.: Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special CommitteeENGLEWOOD, Colo., Nov. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of...
► Artikel lesen
Zynex, Inc.: Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key RolesENGLEWOOD, Colo., Aug. 18, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale...
► Artikel lesen